| Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions LS Tzouvelekis, A Markogiannakis, M Psichogiou, PT Tassios, GL Daikos Clinical microbiology reviews 25 (4), 682-707, 2012 | 1445 | 2012 |
| Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems GL Daikos, S Tsaousi, LS Tzouvelekis, I Anyfantis, M Psichogiou, ... Antimicrobial agents and chemotherapy 58 (4), 2322-2328, 2014 | 706 | 2014 |
| Treating infections caused by carbapenemase-producing Enterobacteriaceae LS Tzouvelekis, A Markogiannakis, E Piperaki, M Souli, GL Daikos Clinical Microbiology and Infection 20 (9), 862-872, 2014 | 401 | 2014 |
| Carbapenemase-producing Klebsiella pneumoniae:(when) might we still consider treating with carbapenems? GL Daikos, A Markogiannakis Clinical Microbiology and Infection 17 (8), 1135-1141, 2011 | 330 | 2011 |
| Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit S Pournaras, A Markogiannakis, A Ikonomidis, L Kondyli, K Bethimouti, ... Journal of Antimicrobial Chemotherapy 57 (3), 557-561, 2006 | 245 | 2006 |
| Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit A Markogiannakis, G Fildisis, S Tsiplakou, A Ikonomidis, A Koutsoukou, ... Infection Control & Hospital Epidemiology 29 (5), 410-417, 2008 | 132 | 2008 |
| Molecular epidemiology of antibiotic resistance of Salmonella enteritidis during a 7-year period in Greece PT Tassios, A Markogiannakis, AC Vatopoulos, E Katsanikou, ... Journal of clinical microbiology 35 (6), 1316-1321, 1997 | 131 | 1997 |
| Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial RT Davey, E Fernández-Cruz, N Markowitz, S Pett, AG Babiker, ... The Lancet Respiratory Medicine 7 (11), 951-963, 2019 | 125 | 2019 |
| Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective GL Daikos, A Markogiannakis, M Souli, LS Tzouvelekis Expert review of anti-infective therapy 10 (12), 1393-1404, 2012 | 110 | 2012 |
| Adaptive resistance to cationic compounds in Pseudomonas aeruginosa A Skiada, A Markogiannakis, D Plachouras, GL Daikos International journal of antimicrobial agents 37 (3), 187-193, 2011 | 101 | 2011 |
| Two novel plasmid-mediated cefotaxime-hydrolyzing β-lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium M Gazouli, E Tzelepi, A Markogiannakis, NJ Legakis, LS Tzouvelekis FEMS microbiology letters 165 (2), 289-293, 1998 | 101 | 1998 |
| Bronchial stump buttressing with an intercostal muscle flap in diabetic patients PG Sfyridis, EI Kapetanakis, NE Baltayiannis, NV Bolanos, ... The Annals of thoracic surgery 84 (3), 967-971, 2007 | 77 | 2007 |
| Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems S Pournaras, A Ikonomidis, A Markogiannakis, N Spanakis, AN Maniatis, ... Journal of medical microbiology 56 (1), 66-70, 2007 | 76 | 2007 |
| Heteroresistance to carbapenems in Acinetobacter baumannii S Pournaras, A Ikonomidis, A Markogiannakis, AN Maniatis, A Tsakris Journal of antimicrobial chemotherapy 55 (6), 1055-1056, 2005 | 69 | 2005 |
| Serum bactericidal activity of three different dosing regimens of colistin with implications for optimum clinical use GL Daikos, A Skiada, J Pavleas, C Vafiadi, K Salatas, P Tofas, K Tzanetou, ... Journal of Chemotherapy 22 (3), 175-178, 2010 | 51 | 2010 |
| Differences in the changes in resistance patterns to third-and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli … G Petrikkos, A Markogiannakis, J Papapareskevas, GL Daikos, ... International journal of antimicrobial agents 29 (1), 34-38, 2007 | 44 | 2007 |
| Multiple Clones within Multidrug-ResistantSalmonella enterica Serotype Typhimurium Phage Type DT104 A Markogiannakis, PT Tassios, M Lambiri, LR Ward, ... Journal of clinical microbiology 38 (3), 1269-1271, 2000 | 42 | 2000 |
| Jeffrey R. Edwardsa*, John S. Bradleyb and Keith P. Klugmanc aCancer and Infection Research, Z eneca Pharmaceuticals, A lderley Park, Macclesfield JA ntimicrob Chemother1998 Journal of A ntimicrobial Chemotherapy 42, 265-279, 1998 | 34 | 1998 |
| Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: evolution over 15 years and temporal association with colistin use by time series … GS Tansarli, J Papaparaskevas, M Balaska, M Samarkos, A Pantazatou, ... International journal of antimicrobial agents 52 (3), 397-403, 2018 | 32 | 2018 |
| VIM-2 metallo-β-lactamase in Achromobacter xylosoxidans in Europe D Sofianou, A Markogiannakis, E Metzidie, S Pournaras, A Tsakris European Journal of Clinical Microbiology and Infectious Diseases 24, 854-855, 2005 | 26 | 2005 |
Athanasios Tsakris, Athanassios TsakrisNational and Kapodistrian University of Athens, Medical SchoolVerified email at med.uoa.gr
